Hi Lolly
The combination of drugs is certainly working for Steve. I suspect his cold sensations and voice changes are all part of the many side effects which we can experience from the cocktail of cancer drugs in our bodies. Because maintenance drugs are not yet approval as regular treatment for myeloma in the UK, perhaps if you read through some of the forum comments on the Myeloma Beacon website where maintenance is more usual in America, you might be able find some more specific answers to your questions about side effects from Steve’s combination of drugs.
Yes, I read the interesting article in the Mail on Sunday about Elotuzumab which is a monoclonal antibody which attaches itself to a specific protein in the myeloma cells helping the immune system recognise these cells and destroy them. The phase 111 clinical trials have been showing some good results from this drug. My consultant is also hopeful about another monoclonal antibody called daratumumab which has been in recent phase 1/11 trials with some promising results. Unfortunately, it’s the length of time we have to wait for these new drugs to be trialled, results to be analysed and if successful waiting for approval in America, Europe and then the UK. Otherwise it’s just being in the right place and right time to wait for these drugs to be available in a local clinical trial. But at least there are a variety of promising drugs coming through the pipeline in the future.
So far, I’ve been very fortunate to have almost achieved five years this September in remission without any drugs. However, my light chains levels still continue to rise with my consultant discussing the issue of relapse treatment.
Love Jan x